Document Detail

Cost-effective strategies in the acute management of atrial fibrillation.
MedLine Citation:
PMID:  10666658     Owner:  NLM     Status:  MEDLINE    
Atrial fibrillation is the most common sustained arrhythmia likely to be encountered in clinical practice. It is associated with significant morbidity and mortality. The treatment of patients with atrial fibrillation can be complex and costly, especially when patients are hospitalized for acute management of this arrhythmia. In this review, we summarize current approaches to the acute management of atrial fibrillation with an emphasis on the most cost-effective approaches. We review acute methods of heart rate control and cardioversion, including pharmacologic and other minimally invasive strategies. We believe that the most cost-effective approaches may require the use of standardized clinical pathways. This may help to ensure that patients with acute atrial fibrillation receive the most effective and efficient care.
J T Dell'Orfano; R K Kramer; G V Naccarelli
Related Documents :
11220518 - Maintenance of sinus rhythm as a therapy goal.
8924058 - Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrilla...
12612318 - Present treatment options for atrial fibrillation.
10364778 - Management of atrial fibrillation: out-of-hospital approach.
22768138 - Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-f...
11999658 - Left atrial thrombus causing pulmonary embolism by passing through an atrial septal def...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in cardiology     Volume:  15     ISSN:  0268-4705     ISO Abbreviation:  Curr. Opin. Cardiol.     Publication Date:  2000 Jan 
Date Detail:
Created Date:  2000-02-24     Completed Date:  2000-02-24     Revised Date:  2006-05-04    
Medline Journal Info:
Nlm Unique ID:  8608087     Medline TA:  Curr Opin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  23-8     Citation Subset:  IM    
Section of Cardiology, State University of New York at Stony Brook, NY 11794-8171, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Arrhythmia Agents / economics,  therapeutic use*
Atrial Fibrillation / economics,  mortality,  therapy*
Cost-Benefit Analysis
Critical Pathways
Electric Countershock / economics,  methods
Risk Factors
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Molecular biology of arrhythmic syndromes.
Next Document:  Catheter ablation in the year 2000.